Seminar on communicable diseases prevention and control

Similar documents
AMR epidemiological situation: ECDC update

Antimicrobial resistance (EARS-Net)

Summary of the latest data on antibiotic resistance in the European Union

What is the problem? Latest data on antibiotic resistance

Table Of Content. Outputs... 8

Surveillance of Antimicrobial Resistance and Healthcare-associated Infections in Europe

Absence of LA-MRSA CC398 as nasal colonizer of pigs raised

Summary of the latest data on antibiotic consumption in the European Union

Antimicrobial resistance and antimicrobial consumption in Europe

Council Conclusions on Antimicrobial Resistance (AMR) 2876th EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS Council meeting

COMMISSION OF THE EUROPEAN COMMUNITIES

Summary of the latest data on antibiotic consumption in the European Union

Postgraduate Technical Workshop Laboratory Diagnosis of Human Parasitic Infections

SECOND REPORT FROM THE COMMISSION TO THE COUNCIL

Exemplary Project. I-4-1-HEALTH - INTERREG April 2018

6-7 November Ministry of Health, Youth, Sport and Voluntary Sector. Pierre Laroque Amphitheater

ECDC activities on antimicrobial resistance & healthcare-associated infections (ARHAI Programme) Ülla-Karin Nurm, ECDC Tallinn, 13 May 2013

European Antibiotic Awareness Day: Promoting prudent antibiotic use in Europe

Regional Workshop on AMR in South East Asia Penang (Malaysia): March 2018

2017 EU Action Plan against AMR state of play of implementation One-Health Network on AMR 26 October Brussels

Questions and answers about methicillin-resistant Staphylococcus aureus (MRSA)

Petya Petkova and Alexandra Hammond- Seaman

ASSEMBLY HALL/FESTIVAL HALL, UNIVERSITY OF BONN, GERMANY

Consumption of antibiotics in hospitals. Antimicrobial stewardship.

WELCOME International Meeting on Emerging Diseases and Surveillance 2007

Initiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector

Prevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices

Assembly Hall/Festival Hall, University of Bonn, Germany

The Commission activities on AMR (focus on zoonotic issues)

Stratégie et action européennes

German Antimicrobial Resistance Strategy DART 2020

Veterinary Emergency Intervention

OIE Platform on Animal Welfare for Europe

Antimicrobial Resistance, yes we care! The European Joint Action

Antibiotic resistance: the rise of the superbugs

Campylobacter infections in EU/EEA and related AMR

A web-based interactive tool to explore antibiotic resistance and consumption via maps and charts

Assembly Hall/Festival Hall, University of Bonn, Germany

MRSA control strategies in Europekeeping up with epidemiology?

OIE activities related to wildlife and biodiversity

The threat of multidrug-resistant microorganisms and how to deal with it in Europe

WHO s first global report on antibiotic resistance reveals serious, worldwide threat to public health

Antimicrobial consumption and resistance in humans in the EU and conclusions from the ECDC-EFSA- EMA JIACRA report

EFSA s activities on Antimicrobial resistance in the food chain. Dr. Ernesto Liebana Head of BIOCONTAM Unit. EFSA

Prof. Otto Cars. We are overconsuming a global resource. It is a collective responsibility by governments, supranational organisatons

Actions for combatting Antimicrobial Resistance (AMR)

Evaluation of EU strategy to combat AMR

Zoonoses in the EU and global context

Dr Nata Menabde Executive Director World Health Organization Office at the United Nations Global action plan on antimicrobial resistance

Quelle politique antibiotique pour l Europe? Dominique L. Monnet

ANTIMICROBIAL RESISTANCE and causes of non-prudent use of antibiotics in human medicine in the EU

EU Action Plan to combat the rising threats from Antimicrobial Resistance: State of play

LA-MRSA in Norway. One Health Seminar 27 June 2017, Ålesund

2016/LSIF/FOR/003 Strengthening Surveillance and Laboratory Capacity to Fight Healthcare Associated Infections Antimicrobial Resistance

National MRSA Reference Laboratory

SURVIVABILITY OF HIGH RISK, MULTIRESISTANT BACTERIA ON COTTON TREATED WITH COMMERCIALLY AVAILABLE ANTIMICROBIAL AGENTS

Activities of the Centre for Zoonoses, Animal Bacterial Diseases and Antimicrobial Resistance (ZOBA) in Switzerland

Birgitte Borck Høg, Senior Scientific Officer Helle Korsgaard, Senior Scientific Officer Tine Hald, Professor National Food Institute, DTU

Annual report of the Scientific Network on BSE-TSE 2015

The challenge of growing resistance

EU Health Priorities. Jurate Svarcaite Secretary General PGEU

Table Of Content. Dutch EU Presidency Conference on Antimicrobial Resistance... 2 Summary... 3 Work Package... 8

ECDC country visit to Luxembourg to discuss antimicrobial resistance issues

Council of the European Union Brussels, 13 June 2016 (OR. en)

Antimicrobial Resistance Prevention (Action Package: Prevent-1) Putting AMR on the priority list: Sweden Dr. Nils Anders Tegnell, Director, The

Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?

RSPCA International- Europe, Turkey and Central Asia. Alexandra Hammond Seaman

AMR situation in Europe: Strategy and vision

Human health impacts of antibiotic use in animal agriculture

Antibiotic usage in nosocomial infections in hospitals. Dr. Birgit Ross Hospital Hygiene University Hospital Essen

Active Bacterial Core Surveillance Site and Epidemiologic Classification, United States, 2005a. Copyright restrictions may apply.

International Food Safety Authorities Network (INFOSAN) Antimicrobial Resistance from Food Animals

WHO global and regional activities on AMR and collaboration with partner organisations

Infection control in Indonesian hospitals

The European AMR Challenge - strategic views from the human perspective -

Decrease of vancomycin resistance in Enterococcus faecium from bloodstream infections in

EFSA s activities on antimicrobial resistance in the food chain: risk assessment, data collection and risk communication.

Tackling the need for new antibacterial drugs

Birgit Ross Hospital Hygiene University Hospital Essen Essen, Germany. Should we screen for multiresistant gramnegative Bacteria?

How do people obtain antibiotics in European countries: an overview

European Medicines Agency role and experience on antimicrobial resistance

Global Conference on Rabies Control: Towards Sustainable Prevention at the Source

WORLD ORGANIZATION FOR ANIMAL HEALTH /OIE/- ENGAGEMENT WITH ANIMAL WELFARE AND THE VETERINARY PROFFESSION

Veterinary antimicrobials: state of play and future developments 2013 European Medicines Agency/IFAH- Europe Info Day 7-8 March 2013

MRSA found in British pig meat

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

Stratégies et actions au niveau européen et international: populations humaines

ESCMID Online Lecture Library. by author

MRSA in the United Kingdom status quo and future developments

OIE Reference Laboratory Reports Activities

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY REFERENCES: MALTA, COUNTRY VISIT AMR. STOCKHOLM: ECDC; DG(SANTE)/

Antibiotics and resistance in the WHO Regional Office for Europe. Dr Nienke van de Sande On behalf of the AMR Working Group

The European road map against antimicrobial resistance

Stray dogs in the EU a Commission contribution

2017 Introduction to Infectious Diseases Clinical Seminar Saturday 30th September - Sunday 1st October 2017 Hotel Grand Chancellor Hobart, Tasmania

Dog/Cat Population Management The CARO approach Sophie Duthoit

The International Collaborative Conference in Clinical Microbiology & Infectious Diseases

EU strategy to fight against Antimicrobial Resistance

Antibiotic Resistance in the European Union Associated with Therapeutic use of Veterinary Medicines

Combating Antibiotic Resistance: New Drugs 4 Bad Bugs (ND4BB) Subtopic 1C. Seamus O Brien and Hasan Jafri Astra Zeneca and MedImmune

Transcription:

Seminar on communicable diseases prevention and control INT MARKT 30085 organised in co-operation with Bulgarian National Center of Infectious and Parasitic Diseases and Directorate General Health and Consumers Venue: Plenary meetings: National Center of Infectious and Parasitic Diseases, 26 Yanko Sakazov Blvd., 1504 Sofia Lecture hall Meeting hall No17 Laboratory works: National Center of Infectious and Parasitic Diseases Reference Center for Control and Prevention of Nosocomial Infections Sofia, 29 September - 2 October 2008 For more information on TAIEX assistance and to download presentations of this event, please go to: http://ec.europa.eu/enlargement/taiex.

Aim of the meeting: The aim of the assistance is to make the Western Balkan countries, Bulgaria and Romania more familiar with the standards and principles for communicable diseases surveillance and control applied in the European Union Network Organising committee: Todor Kantardjiev, National Center of Infectious and Parasitic Diseases, Sofia, Dimitar Nashev, National Center of Infectious and Parasitic Diseases, Sofia Scientific committee: Todor Kantardjiev, National Center of Infectious and Parasitic Diseases, Sofia Dimitar Nashev, National Center of Infectious and Parasitic Diseases, Sofia Jacques Scheres, University of Maastricht Alexander Friedrich, University Hospital Münster, SeqNet.org coordinator INT MARKT 2586230085 2/7

Day I : Monday 29 September 2008 13:00 Registration Surveillance of infectious diseases 1 Chairs: Helmut Walerius, Bogdan Petrunov 14:00 Welcome and introduction Prof. Bogdan. Petrunov, Director of National Center of Infectious and Parasitic Diseases (NCIPD), Sofia Prof. Todor Kantardjiev, Head of Dpt. Microbiology, NCIPD 14:30 Communicable diseases surveillance and control in the EU 15:00 Surveillance of antimicrobial resistance and healthcare-associated infections in Europe Dr. Carl Suetens, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden 15:30 The German dual System for the surveillance of infectious diseases Dr. Inka Daniels-Haardt, State Institute of Health and Labour North-Rhine Westfalia (LIGA NRW) 16:00 Coffee break Surveillance of infectious diseases 2 Chair: Todor Kantardjiev 16:30 BulSTAR Bulgarian system for surveillance of antimicrobial resistance Dr. M. Petrov, National reference laboratory for control and monitoring of antimicrobial resistance, NCIPD 17:00 Epidemiological surveillance system for communicable diseases Dr. Mira Kojouharova, Head of Dpt. of Epidemiology, National consultant for Epidemiology in Ministry of Health 17.30 Discussion 18:00 End of the day INT MARKT 2586230085 3/7

Day II : Tuesday 30 September 2008 08:30 Registration Cross-border healthcare Chair: Jacques Scheres 09:00 Cross-border health collaboration in Europe Prof. Jacques Scheres, University of Maastricht, Netherlands 09:30 Cross-border infectious disease surveillance between Greece and Cyprus Prof. Achilleas Gikas, University of Crete, Greece 10:00 Comparison of the Dutch-German cross-border epidemiology of Methicillin resistant S. aureus (MRSA) within the EUREGIO MRSAnet Twente/Münsterland PD Dr. Alex W. Friedrich University Hospital Münster 10:30 Coffee break 11:00 Laboratory work / Participants presentations and discussion 13:00 Lunch break Healthcare assotiated infections Chair: Smilja Kalenic 14:00 Surveillance of ICU-associated infections in Croatia: a part of the HELICS project Prof. Smilja Kalenic, Clinical Hospital Centre Zagreb 14:30 Resistant bacteria circulating in Macedonian hospitals today and in the past decade Prof. Milena Petrovska, Institute of Microbiology and Parasitology, Medical Faculty, Skopje 15:00 Recent developments in the epidemiology of Acinetobacter Dr. Lenie Dijkshoorn, Leiden University Medical Centre, Netherlands 15:30 Significance of Pseudomonas aeruginosa Resistance Problem and Prevention of Transmission in Healthcare Setting Dr. R. Vatcheva-Dobrevsky, Reference Center for Control and Prevention of Nosocomial Infections, NCIPD, Sofia 16:00 Coffee break 16:30 Laboratory work / Participants presentations and discussion INT MARKT 2586230085 4/7

17:30 End of the day INT MARKT 2586230085 5/7

Day III : Wednesday 01 October 2008 08:30 Registration Typing methods, diagnosis and typing of specific pathogens Chair: Alex Friedrich 09:00 Automation in Microbiology and Molecular rapid identification methods Dr. Ron Hendrix, Laboratorium Microbiologie Enschede, Netherlands 09:30 Community MRSA: what do we need to know? Prof. Wolfgang Witte, National Reference Center for Staphylococci - Robert Koch Institute Wernigerode 10:00 An update on SeqNet.org - spa typing as a communication platform between human and veterinary medicine PD Dr. Alex Friedrich University Hospital Münster, Coordinator of SeqNet.org 10:30 Coffee break 11:00 Laboratory work / Participants presentations and discussion 13:00 Lunch break Agents of bioterrorism, important public health threats Chair: Helmut Walerius 14:00 EU cooperation in health security 14:30 Detection of highly pathogenic bacteria under suspicion of bioterrorism and setting up an European network for diagnosis of these agents PD Dr. Roland Grunow, Centre for Biological Safety (ZBS2) Robert Koch Institute 15:00 Epidemiology and clinical importance of Shiga toxin-producing Escherichia coli (STEC) PD Dr. Alex Friedrich University Hospital Münster 15.30 Legionnaires diseases from the beginning to the present Dr. I. Tomova, Reference laboratory for Legionella, NCIPD 16:00 Coffee break 16:30 Laboratory work / Participants presentations and discussion INT MARKT 2586230085 6/7

17:30 End of the day Day IV : Thursday 02 October 2008 Chair: Alex Friedrich 08:30 Registration 9.00 Laboratory work - analyzing software (Staph Type, Bionumerics)/ Participants presentations 10:30 Coffee break 11:00 General discussion 13:00 End of the seminar This meeting is being organised by the Technical Assistance Information Exchange Instrument of the European Commission CHAR 03/149, B - 1049 Brussels Telephone: +32-2-296 73 07, Fax: +32-2-296 76 94 Web site http://taiex.ec.europa.eu/ INT MARKT 2586230085 7/7